梅州整形抽脂梅州治疗人流手术,梅州慢性盆腔炎能同房吗,梅州慢性附件炎医疗方法,梅州轻度宫颈糜烂的注意事项,梅州一个月来月经怎么办,梅州妇科检查去哪家医院,梅州打胎专家咨询

BEIJING, Nov. 1 (Xinhua) -- Commander-in-chief of China's manned space program Chang Wanquan announced early Tuesday that the launch of Shenzhou-8 unmanned spacecraft is successful.The spacecraft was successfully sent into the designated orbit after the blastoff at 5:58 a.m. at the Jiuquan Satellite Launch Center in northwestern desert area, carried by an upgraded Long March-2F rocket.It is heading to rendezvous with the Tiangong-1, or "Heavenly Palace-1" that was put into space on Sept. 29 for the country's first space docking.The docking, if successful, will pave the way for China to operate a permanent space station around 2020, and make the nation the world's third to do so.The launch was attended by Chinese Vice Premier Zhang Dejiang. It was also observed by senior experts from the European Space Agency and the German Aerospace Center at the launch site.The docking will happen within two days after the launch of the Shenzhou-8 at a height of 343 km above Earth's surface. The spacecraft will return to Earth after two docking operations.

CANBERRA, Dec. 9 (Xinhua) -- Scientists from Australia's University of New England on Friday said they had discovered the remarkably fossil isa metre-long arthropod with excellent vision called anomalocaris from Emu Bay Shale of South Australia.The scientists reported their finding on the anomalocaris in thescience journal Nature this week.It is reported that anomalocaris is a fearsome ancient predator that swam in the Cambrian oceans 500 million years ago. The researchers said the presence of anomalocaris would have driven the development of protective adaptations in prey animals. Such an escalatory 'arms race' would have seen, for instance, the evolution of such adaptations in prey as shells, camouflage and burrowing into sediments. "It has been unbelievably frustrating being able to see eyes like these at fossil sites like the Burgess Shale (in the Canadian Rocky Mountains), but not have any details. It is really refreshing to have our ideas about these animals confirmed at last, " comments Simon Conway Morris, a palaeontologist at the University of Cambridge, the United Kingdom.The research team was led by paleontologist Dr John Paterson, of the University of New England. He said the most surprising discovery of anomalocaris is the huge number of tiny hardened lenses in each eyes."When you consider that a modern housefly, for example, has about 3000 lenses, it's pretty impressive that an animal half a billion years old already has remarkable vision like this," Paterson said in statement."The fact that each eye in anomalocaris would have had over 16, 000 lenses means it would have very, very good resolution."Paterson said the acute vision of Anomalocaris gave it a distinct advantage over competing predators and prey, as many Cambrian animals either had poor vision or were completely blind. Its acute vision rivals or exceeds that of most living insects and was probably comparable to predatory dragonflies today.He said their findings support the idea that compound eyes evolved very early on in arthropod evolution, before the evolution of jointed legs or hardened exoskeletons.The research team hopes they can find the more fossil remains of Cambrian creatures in the Emu Bay Shale.

RIO DE JANEIRO, Oct. 21 (Xinhua) -- Representatives from 120 countries attending the WHO's World Conference on Social Determinants of Health on Friday pledged to maintain investments in healthcare to reduce social gap.A statement adopted at the conference urged governments to maintain international collaboration and promote equal access to healthcare regardless of wealth.Brazilian Health Minister Alexandre Padilha said the economic woes in many countries cannot be a reason to "diminish" their social policies."The crisis cannot be an obstacle, instead it must be an opportunity to consolidate social policies," he said.Brazilian Foreign Minister Antonio Patriota said at the conference that health was an issue related to sustainable development, which will be discussed at the UN's Rio +20 Conference in 2012."The conference that ended today is an important step toward Rio +20," he said.

SAN FRANCISCO, Dec. 8 (Xinhua) -- Twitter on Thursday started to roll out a major redesign of its interface in hopes of simplifying users' experience, as well as new brand pages to strengthen its relationship with advertisers.During a press conference at its new headquarters in San Francisco, Twitter Chief Executive Officer Dick Costolo and co- founder Jack Dorsey unveiled a whole new look of the social networking and microblogging service.According to an introduction video, the new homepage features profile on the left and the timeline on the right, which are flipped from the current positions and take less space than they used to.Three new buttons were also introduced as "Home," "Connect" and "Discover." "Connect" shows users who has mentioned them and suggests some accounts they might want to follow. "When you use Discover, you'll see results reflecting your interests -- based on your current location, what you follow and what's happening in the world," said Twitter.The overhauled interface is only available to a small group of users at first and will be rolled out to all users over the coming months. It will also remain consistent across Twitter's official mobile apps. Twitter has launched a page fly.twitter.com to explain all the changes.Along with the introduction of the redesign, Twitter also announced new brand pages on its platform. A total of 21 brand partners will be included in the initial launch, such as American Express, Best Buy, Bing, Coca-Cola, HP, Disney and Nike.Analysts said Twitter has ambitions to compete with similar brand pages from Facebook and Google+. According to eMarketer, Twitter's global advertising revenue is expected to reach 139.5 million U.S. dollars this year and approach 400 million dollars in 2013.

WASHINGTON, Oct. 13 (Xinhua) -- U.S. researchers have corrected sickle cell disease in adult laboratory mice that had been bred to have the inherited blood disorder by activating production of a special blood component, according to a study published online Thursday in the journal Science.Sickle cell disease results from an abnormality in hemoglobin, the protein found in red blood cells that is responsible for transporting oxygen throughout the body. People living with sickle cell disease have two copies of an altered gene that produces sickle hemoglobin instead of normal adult hemoglobin. Sickle hemoglobin changes shape after releasing its oxygen, causing the red blood cell to become stiff, misshapen and sticky, and slowing blood flow to tissues. This process damages organs and causes pain.The study tested a new approach to increasing the production of a third form of hemoglobin -- fetal hemoglobin. Production of fetal hemoglobin predominates before birth, but turns off thereafter as adult hemoglobin production takes over. People with sickle cell disease are unable to make normal adult hemoglobin, and instead make sickle hemoglobin starting in infancy.An elevated level of fetal hemoglobin within the red blood cell reduces the tendency of sickle hemoglobin to change the shape of red blood cells. Considerable research has shown that the drug hydroxyurea increases production of fetal hemoglobin and reduces the number of pain crises and other complications of sickle cell disease in adults and children. However, not all patients respond well to hydroxyurea, and adverse side effects are a concern.The current study explores a more targeted approach to increasing fetal hemoglobin production. It builds upon earlier studies that discovered a protein called BCL11A normally suppresses the production of fetal hemoglobin soon after birth. The researchers viewed the BCL11A protein as a target for therapy and decided to see what would happen if they blocked production of the protein.The paper details how the research team silenced the mouse gene that produces the BCL11A protein in mice with sickle cell disease. Silencing the gene turned off production of the BCL11A protein and allowed the adult mice to continue to produce fetal hemoglobin. It appears to have eliminated disease symptoms without affecting other aspects of blood production."This discovery provides an important new target for future therapies in people with sickle cell disease," said Susan Shurin, acting director of the U.S. National Heart, Lung, and Blood Institute, which co-funded the study. "More work is needed before it will be possible to test such therapies in people, but this study demonstrates that the approach works in principle."Approximately 100,000 Americans live with sickle cell disease. It is most prevalent in people of African, Hispanic, Mediterranean, and Middle Eastern descent. There is no widely available cure for sickle cell disease. Bone marrow transplants have cured some patients, but the treatment is not without risk and most patients do not have relatives who can donate compatible and healthy bone marrow to them.